ChREBP has roles in lipid metabolism, gluconeogenesis, fructolysis, and glucose-stimulated insulin secretion, all adding to its involvement in NAFLD development in response to carbohydrates (10, 11, 12, 13, 14, 15, 16, 17, 18, 19). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.